Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 86


Bone mineral density and carotid atherosclerosis in systemic lupus erythematosus: a controlled cross-sectional study.

Ajeganova S, Gustafsson T, Jogestrand T, Frostegård J, Hafström I.

Arthritis Res Ther. 2015 Mar 25;17:84. doi: 10.1186/s13075-015-0595-4.


Comparing Five Year Out-Come in Two Cohorts of Patients with Early Rheumatoid Arthritis - A BARFOT Study.

Andersson ML, Forslind K, Hafström I.

Open Rheumatol J. 2015 Feb 3;9:8-15. doi: 10.2174/1874312901409010008. eCollection 2015.


Rheumatoid factor and anti-CCP do not predict progressive joint damage in patients with early rheumatoid arthritis treated with prednisolone: a randomised study.

Hafström I, Engvall IL, Rönnelid J, Boonen A, van der Heijde D, Svensson B; BARFOT study group.

BMJ Open. 2014 Jul 30;4(7):e005246. doi: 10.1136/bmjopen-2014-005246.


Low-dose prednisolone treatment of early rheumatoid arthritis and late cardiovascular outcome and survival: 10-year follow-up of a 2-year randomised trial.

Ajeganova S, Svensson B, Hafström I; BARFOT Study Group.

BMJ Open. 2014 Apr 7;4(4):e004259. doi: 10.1136/bmjopen-2013-004259.


Low levels of antibodies against oxidized but not nonoxidized cardiolipin and phosphatidylserine are associated with atherosclerotic plaques in systemic lupus erythematosus.

Su J, Frostegård AG, Hua X, Gustafsson T, Jogestrand T, Hafström I, Frostegård J.

J Rheumatol. 2013 Nov;40(11):1856-64. doi: 10.3899/jrheum.121173. Epub 2013 Sep 15.


Long-term sustained remission in a cohort study of patients with rheumatoid arthritis: choice of remission criteria.

Svensson B, Andersson ML, Bala SV, Forslind K, Hafström I; BARFOT study group.

BMJ Open. 2013 Sep 10;3(9):e003554. doi: 10.1136/bmjopen-2013-003554.


Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study.

Ajeganova S, Andersson ML, Frostegård J, Hafström I.

J Rheumatol. 2013 Dec;40(12):1958-66. doi: 10.3899/jrheum.130365. Epub 2013 Aug 15.


Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis.

Andersson ML, Svensson B, Petersson IF, Hafström I, Albertsson K, Forslind K, Heinegård D, Saxne T.

BMC Musculoskelet Disord. 2013 Aug 2;14:229. doi: 10.1186/1471-2474-14-229.


Dr. Ajeganova and Dr. Hafström reply.

Ajeganova S, Hafström I.

J Rheumatol. 2013 Mar;40(3):337. No abstract available.


Low-dose prednisolone in early rheumatoid arthritis inhibits collagen type I degradation by matrix metalloproteinases as assessed by serum 1CTP--a possible mechanism for specific inhibition of radiological destruction.

Engvall IL, Svensson B, Boonen A, van der Heijde D, Lerner UH, Hafström I; BARFOT study group.

Rheumatology (Oxford). 2013 Apr;52(4):733-42. doi: 10.1093/rheumatology/kes369. Epub 2012 Dec 28.


Does digital X-ray radiogrammetry have a role in identifying patients at increased risk for joint destruction in early rheumatoid arthritis?

Forslind K, Kälvesten J, Hafström I, Svensson B; BARFOT Study Group.

Arthritis Res Ther. 2012 Oct 15;14(5):R219. doi: 10.1186/ar4058.


Diet and fatty acid pattern among patients with SLE: associations with disease activity, blood lipids and atherosclerosis.

Elkan AC, Anania C, Gustafsson T, Jogestrand T, Hafström I, Frostegård J.

Lupus. 2012 Nov;21(13):1405-11. doi: 10.1177/0961203312458471. Epub 2012 Aug 28.


Carotid atherosclerosis, disease measures, oxidized low-density lipoproteins, and atheroprotective natural antibodies for cardiovascular disease in early rheumatoid arthritis -- an inception cohort study.

Ajeganova S, de Faire U, Jogestrand T, Frostegård J, Hafström I.

J Rheumatol. 2012 Jun;39(6):1146-54. doi: 10.3899/jrheum.111334. Epub 2012 May 15.


Association of obesity with worse disease severity in rheumatoid arthritis as well as with comorbidities: a long-term followup from disease onset.

Ajeganova S, Andersson ML, Hafström I; BARFOT Study Group.

Arthritis Care Res (Hoboken). 2013 Jan;65(1):78-87. doi: 10.1002/acr.21710.


[Rheumatologic research with animal experiments is important for our patients].

Rudin A, Sturfelt G, Carlsten H, Hafström I, Lundberg I, Klareskog L, Rönnblom L, Jacobsson L, van Vollenhoven R, Rantapää-Dahlqvist S, Skogh T, Saxne T.

Lakartidningen. 2012 Jan 11-17;109(1-2):40. Swedish. No abstract available.


Microcirculation as determined by iontophoresis in SLE-patients and controls.

Anania C, Norman M, Heimburger M, Gustafsson T, Jogestrand T, Hafström I, Frostegård J.

Lupus. 2012 Jul;21(8):815-20. doi: 10.1177/0961203312439117. Epub 2012 Mar 13.


Effect of biological therapy on levels of atheroprotective antibodies against phosphorylcholine and apolipoproteins in rheumatoid arthritis - a one year study.

Ajeganova S, Fiskesund R, de Faire U, Hafström I, Frostegård J.

Clin Exp Rheumatol. 2011 Nov-Dec;29(6):942-50. Epub 2011 Dec 22.


Longitudinal levels of apolipoproteins and antibodies against phosphorylcholine are independently associated with carotid artery atherosclerosis 5 years after rheumatoid arthritis onset--a prospective cohort study.

Ajeganova S, Ehrnfelt C, Alizadeh R, Rohani M, Jogestrand T, Hafström I, Frostegård J.

Rheumatology (Oxford). 2011 Oct;50(10):1785-93. doi: 10.1093/rheumatology/ker204. Epub 2011 Jul 9.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk